Background A sirolimus-eluting stent (Cypher, Cordis Corp) has been reported to markedly decrease restenosis in selected lesions; higher-risk lesions, including coronary bifurcations, have not been studied.Methods and results This prospective study evaluated the safety and efficacy of sirolimus-elut...
No comments yet
Be the first to share your thoughts!